Naoyuki Yamaguchi
Overview
Explore the profile of Naoyuki Yamaguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
1014
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yashima K, Kurumi H, Yamaguchi N, Isomoto H
Expert Rev Gastroenterol Hepatol
. 2025 Feb;
:1-20.
PMID: 39968880
Introduction: Advanced therapies (ADT) that encompass biological agents and small molecules have been approved for the treatment of inflammatory bowel disease (IBD), broadening the spectrum of available treatment options. Nevertheless,...
2.
Yamaguchi N, Sakaguchi T, Wei J, Tazoe Y, Inamine T, Fukuda D, et al.
Diagnostics (Basel)
. 2024 Nov;
14(22).
PMID: 39594230
Background: Chronic gastritis caused by () infection can progress to gastric cancer through atrophic gastritis (AG). The risk of gastric cancer increases with the progression of AG. Therefore, investigating the...
3.
Fukuda K, Mizukami K, Yamaguch D, Tanaka Y, Hashiguchi K, Akutagawa T, et al.
PLoS One
. 2024 Nov;
19(11):e0312385.
PMID: 39499715
Background: This study investigated clinicopathological factors associated with the visibility of early gastric cancer and the efficacy of linked color imaging. Methods: Patients with early gastric cancer who underwent endoscopic...
4.
Sakamoto Y, Takeda Y, Yamashita T, Seki Y, Kawahara S, Hirai T, et al.
J Clin Med
. 2024 Sep;
13(18).
PMID: 39336909
: Although peroral cholangioscopy has improved the endoscopic treatment of difficult stones, the treatment of intrahepatic stones remains challenging. The incidence of cholangitis is high when peroral cholangioscopy is used...
5.
Kawasaki-Inomata H, Tabuchi M, Norimatsu K, Honda T, Matsuda K, Hashiguchi K, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272845
The DNA damage response protein p53-binding protein 1 (53BP1) accumulates and forms foci at double-strand DNA breaks, indicating the extent of DNA instability. However, the potential role of 53BP1 as...
6.
Maruya Y, Akazawa Y, Norimatsu K, Sailaubekova Y, Zhumagazhiyeva N, Kobayashi S, et al.
Regen Ther
. 2024 Sep;
26:557-563.
PMID: 39228905
Autologous oral mucosal epithelial cell sheet (AOMECS) transplantation has recently been applied in human patients to prevent postprocedural stenosis following endoscopic submucosal dissection (ESD) for esophageal squamous cell carcinoma. However,...
7.
Tanaka H, Hashiguchi K, Tabuchi M, Nessipkhan A, Akashi T, Shiota J, et al.
Sci Rep
. 2024 Jul;
14(1):17493.
PMID: 39080310
Endoscopic submucosal dissection is a standard treatment for early esophageal squamous cell carcinoma. However, submucosal or lymphovascular invasion increases the risk of lymph node metastasis. Although F-fluorodeoxyglucose positron emission tomography/computed...
8.
Tasaki Y, Yamazaki T, Miyazaki S, Takeda T, Nakatake M, Nakamura D, et al.
BMC Gastroenterol
. 2024 Jul;
24(1):232.
PMID: 39044174
Background: Endoscopic submucosal dissection (ESD) is a potentially efficient therapeutic intervention for superficial esophageal cancer. Additional treatment such as chemoradiotherapy (CRT) or esophagectomy is recommended in cases of muscularis mucosa...
9.
Kanda T, Saiki K, Kurumi H, Yoshida A, Ikebuchi Y, Sakaguchi T, et al.
J Clin Med
. 2024 May;
13(10).
PMID: 38792545
Esophageal achalasia is an archetypal esophageal motility disorder characterized by abnormal peristalsis of the esophageal body and impaired lower esophageal sphincter (LES) relaxation. In this study, the mRNA expression of...
10.
Nakada Y, Sugihara T, Tanaka M, Hamamoto W, Kanda T, Sakaguchi T, et al.
Gastroenterology Res
. 2024 May;
17(2):72-81.
PMID: 38716285
Background: Photodynamic therapy (PDT) has advanced through the utilization of photosensitizers and specific-wavelength light (≥ 600 nm). However, the widespread adoption of PDT is still impeded by high equipment costs...